Busulfan Side Effects
>>>Help Community - Post Your Busulfan Side Effect
More Rx Information: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZAsk about Busulfan Side Effects
Busulfan Safety Reports reported to FDA
Total Busulfan reports: 112.Busulfan FDA safety alerts: No.
Reported deaths: 42 Reported hospitalizations: 44.
Take Busulfan Side Effects Survey or Share Your Busulfan Story.
Reported Busulfan Side Effects: diarrhoea, sepsis, anorexia, acute graft versus host disease, venoocclusive liver disease, malaise, graft versus host disease, stomatitis, stem cell transplant, nausea, liver disorder.
More About Busulfan.
If you have questions about Busulfan, you can ask a Health Expert or Ask Patient Community about Busulfan.
< Previous Showing 101-112 of 112
Busulfan Side Effects Report #5466208-1Consumer or non-health professional from JAPAN reported BUSULFAN problem on Sept 10, 2007. Male patient, 21 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: lower gastrointestinal haemorrhage, thrombocytopenia. BUSULFAN dosage: 25.8 MG; QD; IV; 34.4 ML; QD; IV; 6 ML; QD; IV. During the same period patient was treated with NEUPOGEN, VALPROATE, CYCLOPHOSPHAMIDE, METHOTREXATE, CYCLOSPORINE. Patient recovered.
Busulfan Side Effects Report #5468640-9
BUSULFAN problem was reported by a Health Professional from JAPAN on Sept 11, 2007. Male patient, 60 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, blood culture positive, blood sodium increased, bone marrow transplant, decreased appetite, diarrhoea, escherichia infection, febrile neutropenia, haemodialysis. BUSULFAN dosage: 27 ML; QD; IV; 36 ML; QD; IV; 9 ML; QD; IV. During the same period patient was treated with NEUPOGEN, FLUDARABINE PHOSPHATE, CYTARABINE, VALPROATE, METHOTREXATE, TACROLIMUS. Patient died.
Busulfan Side Effects Report #5468653-7
Health Professional from JAPAN reported BUSULFAN problem on Sept 11, 2007. Female patient, child 6 years of age, was diagnosed with stem cell transplant, prophylaxis against graft versus host disease and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease, anorexia, cytomegalovirus antigen positive, diabetes mellitus, diarrhoea, febrile neutropenia, malaise, oedema mouth, pharyngolaryngeal pain. BUSULFAN dosage: 10.2 ML; QD; IV; 13.6 ML; QD; IV; 3.4 ML; QD; IV. During the same period patient was treated with MELPHALAN, TACROLIMUS, PHENYTOIN, LENOGRASTIM, METHOTREXATE. Patient was hospitalized. Patient recovered.
Busulfan Side Effects Report #5468654-9
BUSULFAN problem was reported by a Health Professional from JAPAN on Sept 11, 2007. Male patient, 43 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease, haemodialysis, meningitis viral, renal impairment, sepsis, stem cell transplant. BUSULFAN dosage: 36 ML;QD;IV. During the same period patient was treated with NEUPOGEN, FLUDARABINE PHOSPHATE, VALPROATE, TACROLIMUS. Patient died on 06/03/2007.
Busulfan Side Effects Report #5468657-4
Health Professional from JAPAN reported BUSULFAN problem on Sept 11, 2007. Female patient, 30 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: febrile neutropenia, haptoglobin decreased, platelet count decreased, red blood cell schistocytes present, thrombotic microangiopathy. BUSULFAN dosage: 26.12 ML;QD;IV. During the same period patient was treated with CYCLOPHOSPHAMIDE, VALPROATE, NEUPOGEN, METHOTREXATE, CICLOSPORIN. Patient died.
Busulfan Side Effects Report #5468658-6
BUSULFAN problem was reported by a Health Professional from JAPAN on Sept 11, 2007. Male patient, 50 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: bone marrow transplant, oedema, staphylococcal sepsis. BUSULFAN dosage: 24.6 ML; QD; IV; 32.8 ML;QD;IV; 8.2 ML;QD;IV. During the same period patient was treated with CYTARABINE, VALPROATE, CYCLOPHOSPHAMIDE, NARTOGRASTIM, METHOTREXATE, TACROLIMUS. Patient was hospitalized. Patient recovered.
Busulfan Side Effects Report #5469880-5
Physician from RUSSIAN FEDERATION reported BUSULFAN problem on Sept 18, 2007. Female patient was diagnosed with bone marrow conditioning regimen and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease. BUSULFAN dosage: 8 MG/KG, OTHER. During the same period patient was treated with FLUDARA, CYCLOSPORINE. Patient recovered.
Busulfan Side Effects Report #5469881-7
BUSULFAN problem was reported by a Physician from RUSSIAN FEDERATION on Sept 18, 2007. Female patient was diagnosed with bone marrow conditioning regimen and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: acute graft versus host disease. BUSULFAN dosage: 8 MG/KG, UNK. During the same period patient was treated with FLUDARA, CYCLOSPORINE. Patient died.
Busulfan Side Effects Report #5469882-9
Physician from RUSSIAN FEDERATION reported BUSULFAN problem on Sept 18, 2007. Female patient was diagnosed with bone marrow conditioning regimen and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: chronic graft versus host disease, scleroderma. BUSULFAN dosage: unknown. During the same period patient was treated with FLUDARA, CYCLOSPORINE. Patient recovered.
Busulfan Side Effects Report #5469883-0
BUSULFAN problem was reported by a Physician from RUSSIAN FEDERATION on Sept 18, 2007. Female patient was diagnosed with bone marrow conditioning regimen and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: chronic graft versus host disease. BUSULFAN dosage: 8 MG/KG, UNK. During the same period patient was treated with FLUDARA, CYCLOSPORINE. Patient recovered.
Busulfan Side Effects Report #5469902-1
Physician from RUSSIAN FEDERATION reported BUSULFAN problem on Sept 18, 2007. Female patient was diagnosed with bone marrow conditioning regimen and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: chronic graft versus host disease, sepsis. BUSULFAN dosage: 8 MG/KG, UNK. During the same period patient was treated with FLUDARA, CYCLOSPORINE. Patient died.
Busulfan Side Effects Report #5474509-6
BUSULFAN problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 28, 2007. Female patient, weighting 201.1 lb, was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: atelectasis, febrile neutropenia, haemoglobin decreased, mucosal inflammation, platelet count decreased, white blood cell count decreased, white blood cell count increased. BUSULFAN dosage: 864 MG. During the same period patient was treated with ETOPOSIDE. Patient was hospitalized. Patient recovered.
< Previous Showing 101-112 of 112